STUDY OF SERUM ADENOSINE DEAMINASE LEVEL IN TYPE 2 DIABETES MELLITUS AND ITS CORRELATION WITH GLYCEMIC CONTROL

Main Article Content

D. Hemalatha
Vinod Kumar R P
P. Ravisekar
T. Rajini Samuel

Keywords

Serum Adenosine Deaminase Level, Type 2 Diabetes Mellitus, Correlation, Glycemic Control

Abstract

Background: Diabetes mellitus (DM) is a chronic endocrine metabolic disorder but largely preventable non communicable disease which is responsible for millions of deaths annually, debilitating complications, and incalculable human misery.  


Objective: To estimate the level of Serum Adenosine deaminase (ADA) among the patients with type 2 diabetes mellitus through a case control study and to evaluate the correlation of Adenosine deaminase with glycemic control (HbA1C).


Methods: The study was conducted in a sample of 60 Type 2 diabetic patients attending diabetic outpatient department and 40 healthy non diabetic individuals who came for routine check -up at Sree Balaji Medical College & Hospital.


Results: ADA levels was significantly high in controlled diabetics (group II with HbA1C < 7) and was much higher in Uncontrolled diabetics (group III with HbA1C > 7) compared to healthy controls (group I). Comparison of the parameters (FBS, PPBS, HbA1C, ADA) between the 3 group was done using Student t test and was statistically significant.  Pearson’s coefficient correlation was done between ADA and HbA1C and found a positive correlation between them and had a statistical significance. This indicates that ADA raises with the extent of severity of type 2 diabetes. Positive correlation of ADA with HbA1C provides the information that ADA can be considered to reflect the glycemic status of the individual.


Conclusions: Adenosine deaminase (ADA) levels are increased in type 2 diabetics and positive correlation of ADA with glycemic control conveys that ADA may serve as a prognostic factor in type II diabetes mellitus. ADA, being an important enzyme for modulating the bioactivity of insulin and its essential role in the effect of insulin   and glycemic control, it may also serve as a tool in assessing the extent of oxidative stress. All these features of ADA provides evidence to suggest ADA as a glycemic marker of type II diabetes

Abstract 32 | pdf Downloads 21

References

1. Robertson RP, Harmon J, Tran PO, Poitout V. Beta - cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53 Suppl 1:S119 -24.
2. King GL, Loeken MR. Hyperglycemia -induced oxidative stress in diabetic complications. Histochem Cell Biol 2004; 122:333 -8.
3. Su Y, Liu XM, Sun YM, et al. The relationship between endothelial dysfunction and oxidative stress in diabetes and prediabetes. Int J Clin Pract 2008; 62:877-82.
4. Thakur S, Chauhan V, Negi RC. Role of HbA1C in diabetes mellitus. Journal of Indian Academy of Clinical Medicine 2009;10(1&2):52-54.
5. Chandalia HB, Krisnaswamy PR. Glycated Hemoglobin. Current Science 2002;83(12): 1522-1532.
6. Chang FY, Shaio MF. Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1995; 28: 137-46.
7. Frankie B, Abbas E. Activated T-lymphocytes in type2 diabetes: Implications from in vitro studies. Curr DrugTargets 2003; 4: 493-503
8. Gitanjali G, Sudeep G, Neerja G, Mili G, Deepak A, Priyanka S. The effect of Hyperglycemia on some biochemical parameters in diabetes mellitus. Journal of Clinical and Diagnostic research 2010; 4:3181-3186.
9. Hovi T, Smyth JF, Allison AC, Williams SC. Role of adenosine deaminase in lymphocyte proliferation. Clin Exp Immunol 1976; 23: 395-403.
10. Sullivan JL, Oxborne WRA, Wedgewood RJ. Adenosine deaminase activity in lymphocytes. Br J Haematol 1977; 37:157-8.
11. Warrier AC, Rao NY, Kulpati DS, Mishra TK, Kabi BC. Evaluation of adenosine deaminase activity and lipid peroxidation level in diabetes mellitus. Indian Journal of Clinical Biochemistry 1995;10(1): 9-13.
12. Kurtul N, Pence S, Akarsu E et al. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove) 2004; 47 (1): 33-5.
13. Hoshino T, Yamada K, Masuoka K et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 1994; 25: 97-102.
14. Baghanha MF, Pego A, Lima MA et al. Serum and pleural adenosine deaminase correlation with lymphocyte populations. Chest 1990; 87: 605-10.
15. Ogbu ISI, Nebo NC, Onyeanusi JC. Adenosine deaminase activities and fasting blood glucose in obesity. Journal of College of Medicine 2006;11(2):115-119.
16. Anjali C. Warrier, Narasimha Y. Rao, Tarun K. Mishra et al. Evaluation of Adenosine Deaminase activity and lipid peroxidation levels in Diabetes Mellitus. Indian Journal of Clinical Biochemistry 1995; 10(1): 9-13